Long exploited by nature for its unique biophysical properties, such as increased nucleophilicity and low pK a , the rare twenty-first amino acid selenocysteine is a promising candidate for incorporation into engineered proteins by synthetic biologists. Unfortunately, the complexity of the selenocysteine incorporation pathway, which requires multiple cis-and trans-acting protein and RNA factors to reassign the opal stop codon (reviewed in detail by Yoshizawa and Böck 1 ), means that recombinant selenoprotein expression is difficult to engineer in common microbial hosts. Furthermore, the selenocysteine-charged tRNA is an inefficient substrate for the translational machinery 2 , and is outcompeted by release factor 2 for access to the UGA codon, resulting in premature termination of protein synthesis. Despite attempts to bypass these constraints on selenocysteine incorporation in bacteria 3,4 , inefficient translation, toxicity, and a lack of genetic tools mean that chemical synthesis remains the most reliable route to engineer new selenoproteins.
A r t i c l e s Long exploited by nature for its unique biophysical properties, such as increased nucleophilicity and low pK a , the rare twenty-first amino acid selenocysteine is a promising candidate for incorporation into engineered proteins by synthetic biologists. Unfortunately, the complexity of the selenocysteine incorporation pathway, which requires multiple cis-and trans-acting protein and RNA factors to reassign the opal stop codon (reviewed in detail by Yoshizawa and Böck 1 ), means that recombinant selenoprotein expression is difficult to engineer in common microbial hosts. Furthermore, the selenocysteine-charged tRNA is an inefficient substrate for the translational machinery 2 , and is outcompeted by release factor 2 for access to the UGA codon, resulting in premature termination of protein synthesis. Despite attempts to bypass these constraints on selenocysteine incorporation in bacteria 3, 4 , inefficient translation, toxicity, and a lack of genetic tools mean that chemical synthesis remains the most reliable route to engineer new selenoproteins.
Previously, we evolved an E. coli tRNA Sec variant 5 that enabled efficient, site-specific selenocysteine incorporation at amber stop codons and overcame the sequence constraints imposed by the endogenous bacterial selenocysteine incorporation machinery. Using this system we produced recombinant proteins containing selenyl-sulfhydryl and diselenide bonds 5 . During our efforts to improve selenoprotein yield, we encountered two separate issues; we observed substantial toxicity from selenocysteine biosynthesis, and discovered that only a subset (<10%) of bacterial cells transformed with plasmids encoding a functional biosynthesis pathway acquired the ability to incorporate selenocysteine (Supplementary Fig. 1 ). We hypothesized that this might be because the recoded E. coli host (RT∆A 5 , which is derived from C321.∆A 6 ) had not adapted to the effects of genomic recoding 6 on regulation and synthesis of the proteome, or because the new redox-active amino acid had attendant fitness burdens.
Whole genome evolution has been used to optimize bacterial fitness, most notably in the laboratory evolution of E. coli over 60,000 generations by the Lenksi group 7 , which resulted in complex genetic adaptations that supported the ability to metabolize a carbon source it couldn't previously use 8 . To facilitate the adaptation of recoded E. coli RT∆A using genome evolution, we coupled cell survival to selenoprotein expression, by creating conditional dependence on an expanded genetic code. This enforces the identity of the UAG stop codon as selenocysteine and ensures cells always exceed a minimum threshold of selenocysteine incorporation required for survival. Whole genome evolution of selenocysteine-dependent lineages of recoded E. coli in parallel led to the isolation of a superior host that enabled production of improved yields of selenoproteins, including those with complex diselenide architectures.
RESULTS

Establishing selenocysteine dependence in E. coli
We produced a selenocysteine-dependent host strain by transforming E. coli RT∆A cells with two plasmids encoding a synthetic selenocysteine biosynthesis pathway consisting of tRNA SecUX , selenocysteine synthase (SelA), selenophosphate synthase (SelD), and O-phosphoseryl-tRNA Sec kinase (PstK) 5 . Strains with different degrees of selenocysteine dependence were established by integrating one of three different variants of the bla NMC-A gene (disulfide-dependent β-lactamase from Enterobacter cloacae) into the chromosome 9 . Incorporation of the rare amino acid selenocysteine to form diselenide bonds can improve stability and function of synthetic peptide therapeutics. However, application of this approach to recombinant proteins has been hampered by heterogeneous incorporation, low selenoprotein yields, and poor fitness of bacterial producer strains. We report the evolution of recoded Escherichia coli strains with improved fitness that are superior hosts for recombinant selenoprotein production. We apply an engineered -lactamase containing an essential diselenide bond to enforce selenocysteine dependence during continuous evolution of recoded E. coli strains. Evolved strains maintain an expanded genetic code indefinitely. We engineer a fluorescent reporter to quantify selenocysteine incorporation in vivo and show complete decoding of UAG codons as selenocysteine. Replacement of native, labile disulfide bonds in antibody fragments with diselenide bonds vastly improves resistance to reducing conditions. Highly seleno-competent bacterial strains enable industrial-scale selenoprotein expression and unique diselenide architecture, advancing our ability to customize the selenoproteome.
A r t i c l e s
The three variants were a wild-type β-lactamase containing the native disulfide bond between C69 and C238 (CC), which did not enforce dependence on selenocysteine, a U69-C238 variant (UC) containing an essential selenyl-sulfhydryl bond, and a U69-U238 variant (UU) containing an essential diselenide bond ( Fig. 1a) . Selenocysteinedependent β-lactamase activity of the UC and UU variants was confirmed by sensitivity to carbenicillin when grown in seleniumfree defined media, which could be rescued by the addition of 1 µM sodium selenite (Na 2 SeO 3 ). A wild-type bla NMC-A gene was also integrated into RT∆A cells containing empty plasmids (∆ strain) to provide a control to identify mutations that accrue independently of selenocysteine incorporation.
We selected for selenocysteine tolerance and improved fitness by serial passage of the four parental strains (CC, UC, UU, and ∆) for 2,500 cell doublings. All experiments were carried out in triplicate, under two different growth conditions that we hypothesized would elicit different adaptive responses. Growth of parental strains was either in an increasing concentration of a β-lactam antibiotic (β populations) or increasing temperature (T populations) ( Fig. 1b) . These conditions were chosen because: (1) they are mildly mutagenic, through induction of DNA polymerase IV, thereby increasing the chance of an adaptive response 10, 11 ; (2) both conditions have previously been used, thus enabling us to compare our results with those already published; (3) both conditions impose stress on selenocysteine biosynthesis and incorporation, but in different ways.
Increasing β-lactam antibiotic concentration exerts selective pressure for increased production of NMC-A β-lactamase, which in turn requires an increase in selenocysteine incorporation. Elevated temperature reduces tRNA Sec stability, which in turn decreases selenocysteine incorporation 12 , and might result in evolution of more stable or more active selenocysteine incorporation machinery.
Evolved E. coli populations bypass metabolic defects Following serial passaging, we observed a substantial increase in fitness of all evolved populations. Growth rates and culture densities increased in all β populations, with particularly large improvements observed for β_UC and β_UU populations, which reached two-to threefold higher culture density and spent 20-40% less time in lag phase ( Fig. 1c and Supplementary Fig. 2) . Similarly, growth of all evolved β populations in a defined selenium-free medium (MOPS EZ), which barely supported growth of the parental cells, was greatly improved ( Fig. 1d and Supplementary Fig. 3 ). This indicates that populations were able to overcome serious defects in core metabolic processes despite being cultured exclusively in rich media. All UC and UU populations retained sensitivity to carbenicillin in MOPS EZ, which could be reversed by supplementation with Na 2 SeO 3 , showing that selenocysteine dependence was maintained throughout the 2,500 generations. No populations acquired unconditional dependence on selenocysteine, which would necessitate Na 2 SeO 3 supplementation in the absence of carbenicillin. 
Populations evolved under thermal stress grew poorly at 45 °C during serial passaging, and most populations had inferior, although highly variable, growth rates and culture density when compared with parental cells grown at 37 °C in rich LB media ( Supplementary Fig. 4 ). This is consistent with previous observations of E. coli MG1655 when it was evolved at elevated temperatures (45-48 °C) 13 . While growth was impaired in rich media, all evolved T populations outgrew parental strains in defined MOPS EZ medium at 37 °C ( Supplementary Fig. 5 ), as was observed for the β populations. All T_UC and T_UU populations retained selenocysteine dependence for carbenicillin resistance.
Genetic analysis of evolved strains
In order to analyze the genetic basis of evolved growth phenotypes, we carried out whole genome sequencing on evolved populations and their parental strains, including RT∆A. Single clonal isolates were also sequenced from each of the β_UC and β_UU populations and were found to be highly representative of the evolved population sequences, containing the same fixed single-nucleotide polymorphisms (SNPs) and no genomic rearrangements. Whole genome sequencing indicated that the selenocysteine biosynthesis and incorporation machinery was maintained throughout evolution, that there was no loss of TAG codons in the bla NMC-A gene and no contamination between the populations. We did not find any genomic suppressor tRNAs via whole genome sequencing. We detected several new in-frame TAG codons in all sequenced genomes, including β_∆ and T_∆ populations, which contained no suppressor tRNAs ( Supplementary Table 1 ). Mass spectrometry of a model protein (GFP) expressed in control strains confirmed that UAG was decoded as glutamine ( Supplementary  Fig. 6 ), which is expected because tRNA GlnCUG is the most efficient near-cognate UAG suppressor 14 .
Genome sequencing identified clusters of SNPs in genes conferring antibiotic resistance (bla NMC-A , ftsI, and ompR), genes mediating oxidative stress or selenite resistance (oxyR and cysK), genes mutated during construction of C321.∆A (ftsA, hemA, pta, and yeeJ), genes involved in plasmid replication (pcnB), and the prfB gene, which codes for release factor 2 ( Fig. 2a) . Genes enriched with SNPs were defined as having acquired SNPs with >50% frequency in four or more independent populations evolved under the same conditions. Notably, no mutations were observed in the selA, pstK, tRNA SecUX , or selD genes which form the synthetic selenocysteine biosynthesis pathway. Supplementary Tables 2 and 3 . (b-e) Growth curves of ftsA G124E, hemA P196L, yeeJ S1467P, and prfB T246A mutants compared to the parental RT∆A strain. Curves are plotted with a line showing the mean and shading representing ± s.e.m., where n = 3 independent biological replicates. Note, ftsA G124E and yeeJ S1467P represent reversions to wild-type MG1655 sequence, which were not directly observed and are discussed in Supplementary Note 1.
The impact of these mutations on fitness was evaluated by introducing a subset of the most enriched SNPs in genes not related to multidrug resistance back into the parental RT∆A strain, using multiplex automated genome engineering (MAGE) 15 . SNPs that we engineered into the parental strain included oxyR A233T, cysK T69I, T73A and H153Y, prfB T246A, N276D, and K282R, and also reversion of the mutations in ftsA, hemA, pta, and yeeJ to the wild-type sequence present in E. coli strain MG1655, the parental strain of C321.∆A. The growth of MAGE-engineered strains was compared with that of RT∆A, and four mutations were identified that simultaneously decreased time spent in lag phase and increased the final culture density ( Fig. 2b-e ). These mutations included three reversions of SNPs that were acquired during construction of the C321.∆A strain, and the prfB T246A mutation, which repairs a defect in release factor 2 that is only present in E. coli K12 strains 16, 17 . Although most of the SNPs we identified either compensated for metabolic defects in the parental recoded E. coli or broadly improved cell growth, cysK and pcnB directly affected selenocysteine tolerance and incorporation. An extended discussion of the SNPs observed in the evolved populations and our efforts to characterize them can be found in Supplementary Note 1, Supplementary  Figures 7-9 , and Supplementary Tables 2 and 3.
Seleno-smURFP: a selenocysteine-specific genetic reporter
Although serial passage improved the fitness of our various populations, it was equally important to assess how well evolved strains produced selenoproteins. While quantitative fluorescent reporter proteins, such as GFP, are used to measure UAG suppression, they cannot discriminate between selenocysteine and competing serine incorporation from Ser-tRNA Sec , the immediate precursor in selenocysteine biosynthesis. Traditional genetic reporters for selenocysteine incorporation are available, such as, formate dehydrogenase, but are only qualitative, due to their narrow dynamic range, and, in addition, they require anaerobic growth conditions 18 .
Therefore, we needed to develop a quantitative selenocysteinedependent fluorescent reporter. In order to differentiate selenocysteine from serine, we co-opted the process of chromophore ligation in phycobiliproteins, which occurs by formation of a thioether bond between a nucleophilic cysteine residue in the protein and a proximal vinyl group in the tetrapyrrole chromophore 19 (Fig. 3a) . This reaction is limited by the nucleophilicity of the cysteine thiol at physiological pH and is not supported by a serine hydroxyl group 20 , so we hypothesized that a selenocysteine residue would support formation of a selenoether cross-link. To this end we replaced the essential cysteine residue in smURFP 20 , an engineered autocatalytic phycobiliprotein, with selenocysteine ( Fig. 3b) . Upon comparison, a C52U variant of smURFP, designated seleno-smURFP, was >20-fold more fluorescent than a C52S variant ( Fig. 3c,d) . The difference in fluorescence between the C52 and C52U variants was likely due to differences in protein abundance, as canonical incorporation of cysteine in response to its cognate sense codons (UGC in smURFP) is more efficient than selenocysteine incorporation in response to UAG. Omission of Na 2 SeO 3 from the culture media abolished fluorescence of seleno-smURFP, which confirmed chromophore ligation was dependent on selenocysteine. Serine incorporation was observed in model proteins expressed in the absence of selenite supplementation (Supplementary Fig. 10 A r t i c l e s for selenocysteine, seleno-smURFP is a robust tool for optimizing selenocysteine biosynthesis and incorporation. We used the seleno-smURFP reporter to measure whether selenocysteine dependence affected retention of the selenocysteine incorporation trait. Cell populations were transformed with a plasmid expressing seleno-smURFP, and 100 transformants were screened for red fluorescence ( Fig. 3e and Supplementary Fig. 11 ). Transformants from populations dependent on selenocysteine incorporation (β_UC, β_UU, T_UC, and T_UU) were almost universally fluorescent, confirming that the ability to incorporate selenocysteine had been retained, independent of the selective pressure encountered during evolution. In contrast, while all three β_CC populations retained the ability to incorporate selenocysteine, the T_CC populations had highly variable rates of selenocysteine incorporation; <10%, 75%, and >90% for T_CC 1-3, respectively ( Supplementary Fig. 11 ). No transformants from populations β_∆ 1-3 and T_∆ 1-3, which lacked the selenocysteine incorporation trait, were fluorescent. Taken together these data indicate that the engineered dependence on selenocysteine was successful and that selenocysteine incorporation was maintained throughout serial passaging.
Evolved strains are superior hosts for selenoprotein synthesis To measure the fold-improvement in selenoprotein expression, transformants from each of the parental strains and the evolved β-lactam populations were assayed for fluorescence in liquid media ( Fig. 3f) . Evolved β_CC and β_UC populations showed five-to sevenfold increases in selenoprotein expression compared to the parental cells. Evolved β_UU populations showed less change from the parental cells, which had much higher fluorescence than either the β_CC or β_UC parental cells. In addition to the increased fluorescence (normalized to cell density), the evolved β_UC and β_UU strains achieved several fold higher cell density (Fig. 1c) , increasing overall selenoprotein yield in some populations up to 20-fold.
A single clone from the β_UU3 population was isolated, and we expressed a series of model proteins containing pairs of selenocysteine residues to calculate the specific selenocysteine incorporation efficiency. EcDHFR U39-U85 and GFP U135-U177 were expressed at yields of 8 and 40 mg/L, respectively, and only intact masses corresponding to selenocysteine incorporation were detected by mass spectrometry (Supplementary Fig. 12 ). Ultraviolet photodissociation (UVPD) of EcDHFR U39-U85 and GFP U135-U177 confirmed complete formation of a diselenide bond between the selenocysteine residues.
To validate diselenide bond formation in clinically relevant protein families with complex bond architectures, we expressed a model antibody fragment (anti-MS2 scFv 21 diselenide formation in both proteins (Supplementary Fig. 13 ). Recent attempts to express recombinant selenoproteins in E. coli 22 , including in genomically recoded E. coli strains, have reported yields in the low mg/L range, with 10-30% selenocysteine content at a single position 22, 23 . Our results represent a substantial advance in terms of yield, incorporation efficiency, and number of selenocysteine residues per protein.
Diselenide bond formation reduces structural heterogeneity
Due to the lower redox potential of diselenide bonds (−381 mV compared to −180 mV for disulfide bonds) 24 , diselenide bond formation is more favorable under reducing conditions than disulfide bond formation, but the consequences of bond replacement on protein structure are unknown. To investigate the effect of diselenide bonds on protein structure, we expressed the Trastuzumab-scFv (Herceptin-scFv), a highly engineered antibody fragment which retains the strictly conserved disulfide bonds in the variable domains, without requiring bond formation to fold 25 . This property allowed us to observe species with both oxidized and reduced cysteine thiols without compromising solubility. As a baseline, wild-type Herceptin-scFv was expressed under reducing conditions in the cytoplasm of E. coli strain BL21(DE3) (12 mg/L), a common host for recombinant protein expression. Using top-down mass spectrometry, we identified a series of intact protein ions normally distributed around the 29+ charge state ( Fig. 4a and Supplementary Fig. 14) and calculated a monoisotopic mass of 27,172.05 Da, corresponding to a sample containing only reduced cysteine residues. UVPD of the 29+ charge state showed an even distribution of fragment ions throughout the protein sequence, confirming a lack of disulfide bonds ( Fig. 4b) .
To assess the effect of disulfide bond formation, we expressed wildtype Herceptin-scFv in T7 Shuffle Express (15 mg/L), an E. coli strain which maintains an oxidizing cytoplasm and constitutively expresses disulfide bond isomerase (DsbC) to facilitate bond formation 26 . The intact protein ions observed during top-down mass spectrometry spanned a broad range of lower charge states, suggesting a mix of reduced and oxidized protein species [27] [28] [29] (Fig. 4c) . We calculated a monoisotopic mass of 27,170.12 Da, corresponding to a species containing only a single disulfide bond. Considering the broad charge state distribution, it is possible that the calculated monoisotopic mass additionally reflects an averaged mass of both fully reduced and fully oxidized species. UVPD fragmentation of the 23+ charge state showed only the V H domain contained a gap in the distribution of fragment ions, confirming the presence of only one disulfide bond ( Fig. 4d and Supplementary Fig. 14) . The identity of the 29+ charge state, potentially a fully reduced species, was unable to be confirmed by UVPD due to the low peak intensity.
In contrast, protein ions from seleno-Herceptin-scFv expressed in β_UU3-T7 cells (0.8 mg/L) were confined to a narrow distribution of lower charge states, consistent with a highly bonded species, and the monoisotopic mass matched a species containing two diselenide bonds (Fig. 4e) . Due to reduced conformational flexibility in the gas phase, disulfide/diselenide-bonded proteins are expected to be observed in lower charge states than their disulfide/diselenidereduced counterparts 30 . Comparison of the charge state distributions of Herceptin-scFvs expressed in E. coli strain BL21(DE3), T7 Shuffle Express, and seleno-Herceptin-scFv expressed in β_UU3-T7 cells further suggest protein populations that were fully reduced, a mixture of reduced and oxidized, and fully oxidized, respectively. UVPD fragment analysis of the 20+ charge state identified gaps in sequence coverage between the pairs of selenocysteine residues in both the V L and V H domains, confirming correct formation of both diselenide bonds ( Fig. 4f and Supplementary Fig. 14) .
Taken together these data confirm that diselenide bonds can reduce sample heterogeneity while ensuring formation of the correct covalent architecture, and suggest that the elevated redox potential of the cytoplasm in T7 Shuffle Express cells is insufficient to completely oxidize cysteine residues, resulting in incomplete disulfide bond formation.
Diselenide bonds confer resistance to reducing conditions
Although diselenide bonds do not provide complete immunity to reduction, the kinetics of bond reformation are faster than disulfide bonds, which has implications for protein stability under reducing A r t i c l e s conditions 31 . This is well established in small peptides where bond formation is the primary driver of structure 32 , but not in proteins, which have independent secondary and tertiary structure. To determine if diselenide bonds could improve protein stability under reducing conditions, we expressed the anti-RCA (ricin A-chain) scFv 33 , which contains two essential bonds, in both disulfide (T7 Shuffle Express, 1 mg/L) and diselenide (β_UU3-T7, 1 mg/L) configurations, as confirmed by mass spectrometry ( Fig. 5 and Supplementary  Fig. 15 ). Proteins were incubated with varying concentrations of dithiothreitol (DTT), which we hypothesized would reduce both disulfide and diselenide bonds, but prevent reformation of only the disulfide bonds. DTT treatment impaired binding of the disulfidebonded scFv at all concentrations tested (1, 10, and 50 mM), whereas the diselenide-bonded scFv was only mildly affected by 50 mM DTT, the highest concentration tested (Fig. 5c,f) . Given that the disulfide bonds in antibody fragments are buried in the core of the variable domains, further increased stabilization might be observed in proteins with more solvent-accessible bonds, such as EGF-family proteins.
DISCUSSION
We engineered an improved bacterial host for selenoprotein expression by endowing E. coli strains with conditional dependence for incorporation of selenocysteine using an amber suppressor tRNA Sec variant and an engineered β-lactamase containing an essential diselenide bond. Dependence on selenocysteine incorporation was maintained for more than 2,500 generations, allowing cell populations to evolve tolerance to constitutive selenocysteine biosynthesis and acquire several mutations that improved cell fitness. This is the first demonstration, to our knowledge, of enforcing an expanded genetic code to facilitate host adaptation and improve recombinant protein production. We anticipate that selected mutations identified in our study could be integrated into recoded E. coli strains 34 that have been optimized using different methods. With recent advances in orthogonal translation systems 35 and protein design, this type of approach should prove generalizable to other amino acids in other proteins [36] [37] [38] . Previous attempts to improve genomically recoded E. coli strains have focused exclusively on growth rate 34, 39 but have found less substantial improvements in the suppression of UAG codons by non-canonical amino acids. Using our evolved strains, we have greatly expanded the number of selenocysteine residues that can be site-specifically incorporated into recombinant or endogenous proteins, enabling the production of selenoproteins containing multiple diselenide bonds, such as seleno-antibody fragments. These strains can be used in future efforts to engineer and customize the selenoproteome and, along with the development of new tools such as diselenide bond isomerases, may enable protein engineers to access complex nonsequential diselenide bond configurations.
We developed a fluorescent reporter, seleno-smURFP, that enabled us to confirm that our evolved E. coli populations were superior hosts for recombinant selenoprotein expression. Seleno-smURFP enables quantitative measurement of selenocysteine incorporation in vivo and will facilitate rapid optimization of the selenocysteine biosynthesis machinery. Using our evolved E. coli host (strain β_UU3) we expressed a diverse set of recombinant selenoproteins containing diselenide bonds with yields, selenocysteine incorporation efficiency, and diselenide bond complexity that are superior to previous attempts 22 . Furthermore, we report improved formation of diselenide bonds compared with disulfide bonds in the bacterial cytoplasm, and confirm that diselenide bonds in recombinant proteins can confer resistance to reducing conditions. Diselenide bonds have been used to improve the stability and biological half-life of therapeutic peptides, such as insulin 40 and oxytocin 31 , which are manufactured using solid-phase synthesis. The ability to efficiently introduce diselenide bonds into recombinant proteins extends this stabilizing motif to previously inaccessible classes of protein therapeutics, and provides a high-throughput approach to improve existing therapeutics.
In addition to enabling the incorporation of diselenide bonds as a protein engineering tool 41 , a reliable host for recombinant selenoprotein expression will find broad utility among the wider protein biology community. Replacing catalytic cysteine residues in enzymes with selenocysteine has enabled advances in mechanistic enzymology 42, 43 , but progress has been hindered by inefficient protein expression in cysteine auxotrophs or by specialized protein ligation strategies 44 . In addition, these approaches have inherent limitations, requiring either the removal of native cysteine residues or accepting indiscriminate selenocysteine incorporation, or maintaining the solubility of truncated enzyme fragments.
Similarly, efforts to characterize the human selenoproteome (comprising 25 proteins of which half are uncharacterized) have relied on auxotrophic selenocysteine incorporation 45 , or replacement of catalytic selenocysteine residues with cysteine to overcome the difficulty of expression at the cost of producing proteins with low activity and unknown biological relevance 46 . Recent attempts to produce two of these proteins have been successful using complete chemical synthesis of entire selenoproteins 47 . Expression in a bacterial host will enable easier analysis of these proteins.
Furthermore, selenocysteine-dependent conjugation chemistries 48 , methods currently employed by peptide chemists, can now be expanded to recombinant proteins using our strains, making orthogonal drug conjugation easier by removing the need to eliminate other reactive surface residues.
We envision that the tools and host strains for highly efficient sitespecific selenocysteine incorporation that we report here will serve as a platform for exploring the potential of the selenoproteome and seleno-stabilized therapeutics.
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ONLINE METHODS
Molecular biology. The plasmids described in this work were constructed using Gibson assembly and standard molecular biology techniques. Synthetic genes were obtained as gBlocks from IDT. Relevant DNA sequences including those of representative plasmids can be found in Supplementary  Tables 4-13 .
To construct the parental E. coli strains for the passaging experiment, RT∆A cells were transformed with pKD78 and either pRSF-SelA-PstK (Supplementary Table 6 ) and pCDF-SelD-UX (Supplementary Table 7) or empty pRSF and pCDF vectors, containing only the origin of replication and the antibiotic resistance marker. RT∆A cells containing the three plasmids were grown to mid-log phase at 30 °C and the lambda red recombinase machinery induced by addition of L-arabinose to a final concentration of 0.3% and incubation for 1 h at 37 °C. Electrocompetent cells were prepared from the induced cultures by washing cells three times in 10% glycerol. Cells were transformed with 200 ng linear double-stranded DNA encoding the bla NMC-A gene under the control of the Serratia marcescens P blaSME-1 promoter with 50-bp homology arms complementary to the E. coli ahpC locus ( Supplementary Table 8 ). RT∆A cells containing pRSF-SelA-PstK and pCDF-SelD-UX were transformed with a wild-type bla NMC-A gene (C69-C238), a bla NMC-A gene containing a C69U mutation, or a bla NMC-A double mutant containing the C69U and C238U mutations. RT∆A cells containing the empty pRSF and pCDF vectors were transformed with the wild-type bla NMC-A gene only. Cells were plated on LB agar supplemented with 50 µg/mL kanamycin, 100 µg/mL spectinomycin, and either 50 or 100 µg/mL ampicillin. Plates for the U69 and U69-U238 variants were supplemented with 10 µM Na 2 SeO 3 . No U69-U238 colonies developed on the 100-µg/mL plate, and an extended incubation (48 h) was required to develop colonies on the 50-µg/mL plate. Resulting ampicillin-resistant colonies were screened by PCR to identify correct integrations, which were confirmed by Sanger sequencing. A single verified clone from the RT∆A cells containing the empty pRSF and pCDF vectors was designated the ∆ parent strain. Single verified clones containing the pRSF-SelA-PstK and pCDF-SelD-UX plasmids and the three bla NMC-A gene variants (wild-type, U69, and U69-U238) were designated the CC, UC, and UU parent strains, respectively.
To construct a strain with improved characteristics for protein expression, we integrated the T7 RNA polymerase gene into a clonal isolate of β_UU3. A cassette was assembled that encoded T7 RNAP under the control of the P LtetO promoter and a constitutively expressed bicistronic sequence containing the aac3 gene conferring gentamicin resistance and the tet repressor. This cassette was flanked by 500-bp homology arms corresponding to the E. coli lac locus ( Supplementary Table 9 ) and the entire fragment cloned into an R6K plasmid derived from pKD4. The T7 RNAP cassette including the lac homology arms was amplified by PCR and integrated into a clone of β_UU3 containing pKD78 as described for bla NMC-A . Gentamicin-resistant colonies were screened by PCR and the sequence of the T7 RNAP and tet repressor confirmed by Sanger sequencing. The resulting strain was designated β_UU3-T7.
NMC-A -lactamase assay.
To assess the toxicity of selenocysteine biosynthesis and identify a possible threshold effect for selenocysteine incorporation, RT∆A cells were transformed with p15A-NMC-A (U69-U238) (Supplementary Table 5 ) and one of two pRSF-UX-SelA variants: one encoding a wild-type selA gene ( Supplementary Table 4 ) and one encoding a selA gene truncated by a stop codon. Cells were recovered in SOC for 1 h and then diluted into 20 mL LB containing 50 µg/mL kanamycin, 12.5 µg/mL tetracycline, and 10 µM Na 2 SeO 3 and incubated overnight. Tenfold dilutions were performed from the saturated cultures and plated on LB agar containing 50 µg/mL kanamycin, 10 µM Na 2 SeO 3 , and either 12.5 µg/mL tetracycline or 100 µg/mL carbenicillin.
Bacterial passaging. 5-mL cultures of LB supplemented with 25 µg/mL kanamycin, 50 µg/mL spectinomycin, 10 µM Na 2 SeO 3 , and 100 µg/mL carbenicillin were inoculated in triplicate with the ∆, CC, UC, and UU parent strains. Following growth to stationary phase, cells were diluted 5,000-fold into fresh media resulting in ~12.5 doublings every passage. Glycerol stocks were prepared from all cultures every five passages and the selection stringency was increased every ten passages. During the β-lactam resistance experiment, stringency was adjusted by increasing the carbenicillin concentration by 100 µg/mL. This continued evenly until 2,500 cell doublings had occurred. For the thermal tolerance experiment, the temperature was increased by 0.5 °C (and the carbenicillin concentration kept constant at 100 µg/mL). At an incubation temperature of 43.5 °C, some cultures could no longer be passaged reliably when the freshly diluted cells were immediately incubated at 43.5 °C. To overcome this problem, all cultures in the thermal experiment were pre-incubated at 43 °C for 3 h and then the incubation temperature elevated to the correct level. At 45.5 °C several cultures had poor viability even with a 43 °C pre-incubation, and all remaining passages were performed at 45 °C.
For the competition experiment between wild-type RT∆A cells and those carrying mutant cysK alleles, strains were initially grown to saturation, diluted to OD 600 0.1 and mixed in a 1:1 ratio. 5-mL cultures of LB supplemented with 33 µg/mL zeocin and ± 10 µM Na 2 SeO 3 were inoculated in triplicate with 1 µL of the RT∆A:mutant cell mix. Cultures were incubated at 37 °C and serially passaged to saturation ten times (125 generations).
Whole genome sequencing and bioinformatic analysis. Genomic DNA from RT∆A cells, the parental ∆, CC, UC, and UU stocks and each evolved bacterial population was extracted from ~5 × 10 9 cells using a Zymo Research Fungal/Bacterial DNA Kit according to the manufacturer's instructions. DNA was prepared for sequencing with a 300 base-pair target insert size using standard methods. Samples were sequenced on an Illumina HiSeq 2500 system using 125 base-paired-end reads at the Genome Sequencing and Analysis Facility (University of Texas at Austin). Across all sequenced bacterial lines, an average coverage of 144.4× was obtained with a s.d. of 43.0. Raw sequencing reads were processed by trimming and removing adapters using trimmomatic (v0.32). The sequence of the RT∆A genome was assembled using the De novo Assembly Module in Geneious. Variant detection was performed using breseq (v0.27.0), with the assembled RT∆A genome and plasmid sequences as references. Mutations occurring at or above 20% in the ∆, CC, UC, and UU parental strains were removed in their respective evolved populations. Genes enriched with SNPs were defined as having acquired SNPs with >50% frequency in four or more independent populations evolved under the same conditions. MAGE. 100 µL of RT∆A cells containing pKD78 from a saturated culture was diluted into 3 mL of LB supplemented with 33 µg/mL chloramphenicol and grown to mid-log phase at 30 °C. To induce the lambda red-recombination machinery, 100 µL of 10% w/v l-arabinose was added to give a final concentration of 0.3% and the cells transferred to 37 °C and incubated for 1 h. One mL of the induced culture was removed and centrifuged at 8,000g for 1 min to pellet the cells. Cell pellets were resuspended in 10% glycerol and washed three times to prepare electrocompetent cells. Mutagenic oligonucleotides were added to a final concentration of 1 µM each. Cells were electroporated at 1.8 kV, 25 µF capacitance and 200 ohms (Bio-Rad E. coli Pulser) and recovered in three mL LB supplemented with chloramphenicol. Cells were grown to mid-log phase and an additional two MAGE cycles were performed as described above. Following a final 3-h recovery, tenfold serial dilutions were plated on LB supplemented with 33 µg/mL zeocin to obtain single colonies. Mutants were identified using multiplex allele-specific colony (MASC)-PCR, after which the target genes were amplified by PCR and mutations confirmed by Sanger sequencing.
Growth assays. Parental and evolved E. coli strains were characterized by growth assays in both rich and defined media. For characterization in rich media, 5-mL cultures of LB containing 25 µg/mL kanamycin, 50 µg/mL spectinomycin, and 10 µM Na 2 SeO 3 were inoculated from glycerol stocks and grown to saturation. Aliquots of each culture were diluted to OD 600 1.0 and 1 µL used to inoculate 100-µL cultures, in triplicate, comprising four different carbenicillin concentrations in a 96-well plate. The growth assay media consisted of LB containing 25 µg/mL kanamycin, 50 µg/mL spectinomycin, 10 µM Na 2 SeO 3 , and the four carbenicillin concentrations were 0, 100, 1,000, or 10,000 µg/mL. Plates were sealed with an optically clear, gas-permeable membrane and incubated with constant orbital agitation (amplitude of 3 mm) at 37 °C. OD 600 measurements were taken at 5-min intervals for 24 h (Tecan Infinite M200 Pro). Populations evolved with β-lactam stress were assayed using all four carbenicillin concentrations. Populations evolved with thermal stress were only assayed at 100 µg/mL carbenicillin. All growth curves are plotted as the mean of three biological replicates performed in technical triplicate ± s.e.m. represented as ribbon.
For characterization in defined media, cultures were started in MOPS EZ containing 0.5 µg/mL d-biotin, 25 µg/mL kanamycin, and 50 µg/mL spectinomycin. Parental strains were observed to grow poorly in MOPS EZ and cultures were diluted to OD 600 0.1 rather than 1.0. Growth assays were performed as previously described using four variations of the MOPS EZ media used for overnight growth; media only, media containing 100 µg/mL carbenicillin, media containing 1 µM Na 2 SeO 3 and media containing both carbenicillin and Na 2 SeO 3 . Mutant strains generated by MAGE were assayed as described above in either LB supplemented with 33 µg/mL zeocin or MOPS EZ containing 33 µg/mL zeocin and 0.5 µg/mL d-biotin. Na 2 SeO 3 was supplemented at 10 µM in LB and 1 µM in MOPS EZ. Growth curve data are representative of two or three repeated experiments.
qPCR and mutant allele detection. RT∆A cells along with the polA and pcnB mutants were transformed with the pRSF and pCDF empty plasmids. Replicates of each of the three clones for each mutant/plasmid pair were grown to saturation and then diluted 1:100 in a 96-well plate. Plates were incubated in a plate reader (BioTek Cytation 5) at 37 °C for 4 h with constant agitation, where OD 600 was monitored. Following incubation the plates were removed and put on ice, where a 2-µL aliquot from each well was added to a qPCR reaction mix containing EvaGreen double-stranded DNA dye, and qPCR primers specific for either the aphA1 or aadA genes from pRSF and pCDF, respectively. Purified plasmid DNA was quantified, diluted, and used as a standard on each qPCR plate for quantification. Fluorescence was read and analyzed using a Roche Lightcycler 96. Absolute quantifications of each sample were normalized to the OD 600 of the well corresponding to the sample.
For detection of mutant cysK alleles, cultures were inoculated from glycerol stocks taken from the final serial passage for each sample and incubated at 37 °C with 225 r.p.m. agitation. For samples passaged with selenite, the medium was supplemented with 10 µM Na 2 SeO 3 for any further growth. Saturated cultures were diluted 1:50 in LB and incubated for 3 h until reaching mid-log phase. 1.5-mL aliquots of each culture were normalized to the highest OD 600 (~0.4) and centrifuged at 3,500g for 5 min, then resuspended in 100 µL of LB. Cells were then boiled for 15 min at 95 °C to prevent PCR inhibition. Cell debris was pelleted by centrifugation and the supernatant was recovered. Primers specific for wild-type and mutant alleles at T69, T73, and H153 were designed as previously described 49 . Oligos were purchased from IDT (Coralville, IA). Triplicate qPCR reactions (20 µL) were set up using 500 nM Forward and Reverse primer, 10 µL of 2× Fast EvaGreen qPCR Master Mix (Biotium, Inc., Fremont, CA), and 2 µL of cell supernatant from each sample. Reactions were run on the Roche LightCycler 96 and analyzed using the manufacturer's software. qPCR data shown are representative of three experiments. smURFP optimization and fluorescent reporter assays. To make plasmid pUC-BAD-smURFP (Supplementary Table 10) , a fragment containing the araC gene, the P BAD promoter and the bicistronic smURFP-pbsA1 was amplified from pBAD-smURFP-RBS-HO-1 (Addgene plasmid # 80341) and cloned into a Cm R derivative of pUC19. The TAG stop codon in pbsA1 (encoding Synechocystis sp. PCC 6803 heme oxidase) was changed to TAA during this process. Expression of smURFP and heme oxidase in E. coli DH10B from either pUC-BAD-smURFP or pBAD-smURFP-RBS-HO-1 resulted in green cultures or colonies, which were highly fluorescent in the red spectrum. In contrast, RT∆A cells or β_UU3 cells transformed with pUC-BAD-smURFP and induced with 0.33% L-arabinose were not visibly green and were only weakly fluorescent. This was assumed to be due to a lack of the biliverdin chromophore, likely a result of defects in the heme biosynthesis pathway limiting the pool of intracellular heme. Both strains contain a L196P mutation in HemA, which catalyzes the initial and rate-limiting step of heme biosynthesis in E. coli, a mutation inherited from C321.∆A known to deleteriously affect cell growth. To overcome this problem, 5-aminolevulinic acid (5-ALA) was added to bypass HemA and increase flux through the heme biosynthesis pathway. Fluorescence assays were performed with varying concentrations of 5-ALA and a final concentration of 100 µg/mL was found to result in cells, which were visibly green and highly fluorescent.
Cells transformed with pUC-BAD-smURFP variants (C52, S52, U52, TAA52) were grown to saturation in LB supplemented with 25 µg/mL kanamycin, 50 µg/mL spectinomycin, 100 µg/mL carbenicillin, 33 µg/mL chloramphenicol and 10 µM Na 2 SeO 3 . Cultures were diluted 1/45 into 900 µL fresh LB containing antibiotics and 0, 10, or 25 µM Na 2 SeO 3 and incubated at 37 °C with agitation in a 2 mL 96-well plate for 3 h. Cells were induced by the addition of 100 µL of media containing 3.3% l-arabinose to achieve a final concentration of 0.33%. Cultures were incubated for 16 h and the cells recovered by centrifugation. Cell pellets were resuspended in PBS and fluorescence was measured using excitation and emission wavelengths of 633 and 695 nm respectively. Fluorescence was normalized to OD 600 . For smURFP assays on solid media, aliquots were taken from saturated overnight cultures, diluted to OD 600 0.1 and 3 µL dotted onto agar plates containing appropriate antibiotics, 0.33% l-arabinose and 0, 10, or 25 µM of Na 2 SeO 3 . Plates were imaged with a Chemi Doc MP imaging system (Bio-Rad) using a manual exposure of 0.1 s and analyzed using Image Lab 5.2.1.
Protein purification.
Coding sequences for DHFR, GFP variants, and anti-MS2 scFv were cloned into a p15A-PcaU plasmid ( Supplementary Table 11 ) with a C-terminal His6-tag. Plasmids were transformed into electrocompetent β_UU3 cells and single transformants grown to saturation in LB supplemented with 1,000 µg/mL carbenicillin, 12.5 µg/mL tetracycline, and 10 µM Na 2 SeO 3 . Cultures were diluted 1/250 in terrific broth supplemented with antibiotics and 25 µM Na 2 SeO 3 in baffled flasks and incubated at 37 °C with agitation (250 r.p.m.) until reaching mid-log phase. Protein expression was induced by addition of 3,4-dihydroxybenzoic acid to achieve a final concentration of 1 mM. 3,4-dihydroxybenzoic acid was added from a 10× stock, which was freshly prepared in culture media. The optimal induction period and temperature were established for each protein individually. Cells were harvested by centrifugation at 8,000g for 10 min and the cell pellets resuspended in 25 mL of wash buffer (50 mM K 2 HPO 4 , 300 mM NaCl, and 10% glycerol at pH 8.0) with protease inhibitor cocktail (cOmplete, mini EDTA free, Roche) and lysozyme (0.5 mg/mL). Cells were incubated for 20 min at 4 °C with gentle agitation and lysed by sonication (Model 500, Fisher Scientific). Lysate was repeatedly clarified by centrifugation (35,000g for 30 min), filtered through a 0.2-µm membrane and protein recovered by immobilized metal ion affinity chromatography (IMAC) using Ni-NTA resin and gravity flow columns. Eluate was concentrated and dialyzed into the appropriate buffer followed by purification to apparent homogeneity by size exclusion fast protein liquid chromatography (FPLC). DHFR was dialyzed into 50 mM NH 4 Ac pH 6.5, GFP variants were dialyzed into 50 mM potassium phosphate pH 7.0 and hGH and all scFvs were dialyzed into TBS pH 7.5.
Human growth hormone (hGH), seleno-Herceptin-scFv and anti-RCA scFvs were expressed from either p15A-P T7 or pUC-P T7 plasmids (Supplementary Tables 12 and 13) . Proteins were expressed and purified as described above except using β_UU3-T7 cells that were induced by the addition of anhydrous tetracycline to a final concentration of 200 ng/mL. Wild-type Herceptin-scFv was cloned into pET-11a and expressed in E. coli strains BL21(DE3) and T7 Shuffle express. Protein yield following size-exclusion chromatography (SEC) was measured by BCA assay (Pierce BCA Protein Assay Kit, Thermo Scientific) using bovine serum albumin as a standard. GFP, aMS2, and hGH were expressed in multiple batches, and the reported yield corresponds to the batch for which mass spectra are presented. GFP U135-U177 was used to validate selenoprotein expression using a number of different expression plasmids, media compositions and other culture parameters. Yields ranged from 10-40 mg/L depending on conditions. The anti-MS2 scFv was expressed in three batches with final yields of ≤1 mg/L, although substantial precipitation was observed during purification and storage. Seleno-hGH was expressed in three batches with yields ranging from 5-9 mg/L. Yield information for other proteins is based on a single-batch purification from a total culture volume of 1 liter under the conditions described above.
Mass spectrometry. Samples were desalted using either a Millipore 10-kDa molecular weight cutoff filter (Darmstadt, Germany) or a Bio-Rad Micro
